Discussion
Tailgut cysts (TGCs), also known as retro-rectal cystic hamartoma (RCH) or epidermoid cysts in presacral and retro-rectal space, are cystic lesions that occur due to developmental abnormalities in the embryonic pathways and they are the remnants of the embryonic hindgut. (1) Tailgut cysts are very rare, have an incidence rate of 1 of 40,000–63,000 patients, and are more common in middle-aged women. (2,3)
Histologically, TGCs are multilocular cysts with squamous, mucinous, simple, pseudostratified ciliated, or transitional lining cells or may contain bundles of smooth muscle in the cyst’s wall. Meningeal tissue, thyroid tissue, and glomus bodies have also been reported (4).
The clinical manifestations of TGC can range from asymptomatic to atypical clinical symptoms because of compressive effects of mass, including constipation, rectal filling, dyschezia, infertility, dysuria, and abdominal pain. The infectious process like repeated urinary tract infection, abscess, and fistula formation may also occur with symptoms including high fever, pain, and frequent micturition. (5–11)
Differential diagnoses that should be considered for retro-rectal masses include anal gland cyst, duplication cyst, endometriotic cyst, sacral meningocele, or pilonidal sinus. (4)
Although FNA or other cytological biopsies have been recommended in some older articles, tissue sampling has not been recommended in more recent data due to the risk of the tumor spreading into the abdominal cavity, and the role of imaging in preoperative diagnosis has become more prominent. (12) Tissue biopsy might be considered only for patients with high surgical risks who are not a candidate for surgery. We may have to find out about the pathology through the biopsy in this setting. (9)
CT and MRI are required to diagnose and characterize differential diagnosis and treatment strategies. (10,11) Malignant and benign lesions show different characteristics on MRI examination, especially on T2-weighted images (12). Sarkar et al. believed that radiological examination could contribute to diagnosing cystic lesions in the presacral space; however, the definitive diagnosis can only be achieved by surgical exploration and histological examination (13).
Malignant transformation in TGCs can occur but are rare, and the clear pathogenesis remains unknown. The most frequent histological types include adenocarcinoma and neuroendocrine tumors. Others include carcinoid tumors, squamous cell carcinoma, endometrioid carcinoma, adenosquamous carcinoma, transitional cell carcinoma, and sarcoma were rarely reported (5,9,14). Squamous cell carcinoma was previously reported in just four reports (15–17), and our case was the fifth.
Generally, the reported incidence rate of malignant tumors arising from epidermoid cysts is 0.011 % –2.2 % (6,7). However, a higher rate of malignant transformation has been reported in some reviews of TGCs. Feng Liang et al. have mentioned in a review article that about 30 % of reported cases of TGCs in the literature were malignant. (8) It could be probably due to the higher chance of developing symptoms in these malignant cases. Therefore they are more likely to be diagnosed. Similarly, K. Nicoll et al. have also reported that the overall rate of neoplastic transformation was 26.6% and noted the low metastatic rate in these malignancies. (18) We have found only 2 cases of metastasis in the literature review which were SCC and NET. (15,19)
The treatment of choice for all TGCs is complete surgical excision. Additional chemotherapy or radiation therapy treatments are given if malignancy is detected based on the pathology report. The minimally invasive transanal or transrectal approach is indicated for small low-lying, non-infected cases because of the risk of pelvic infection in these surgical approaches (20). A transabdominal surgery approach is preferred in patients with suspected malignancy because of better access and visualization for a complete oncological surgery(20).
In the case of pre-rectal cysts, of which Tailgut cysts can be one, the possibility of malignant transformation should be considered, and in this case, surgical resection and complete evacuation of the cyst with a suitable margins may be the best measure for potential diagnosis and treatment of these lesions. In our case, complete oncological surgery was not performed, leading to early disease progression and metastasis despite chemo-radiation therapy. This case highlights the critical role of extensive surgery, and if it is not expected to be possible, neoadjuvant treatments may facilitate this goal. If surgery is done first, it would be logical to consider adjuvant therapies. Eventually, there is no conclusive guideline or standard policy on adjuvant treatment indications in malignant tailgut cysts. Further research is needed, so treating such patients in a multidisciplinary team is reasonable.